Try our Advanced Search for more refined results
Corporate
-
February 05, 2026
Alston & Bird Hires Ex-Baker McKenzie Tech, Privacy Pro
Alston & Bird LLP has added a technology and privacy specialist previously with Baker McKenzie as a partner in its Silicon Valley office, the firm announced Thursday.
-
February 04, 2026
Albright Axes Texas' Anti-ESG Law As Unconstitutional
Texas' law restricting state investments with financial firms and businesses that want to reduce their reliance on fossil fuels is both "overbroad and unconstitutionally vague," a federal judge has ruled, handing a sustainability-focused business group a summary judgment victory.
-
February 04, 2026
Medtronic Owes $381M For Antitrust 'War Games,' Jury Told
An attorney for Applied Medical told a California federal jury Wednesday during closing arguments in an antitrust trial against Medtronic that internal documents from the medical device giant show it played illegal "war games" against his client and should pay up to $381 million.
-
February 04, 2026
Wash. AG Defends 'Constitutional' Anti-Spam Law In Ulta Suit
Washington's attorney general is defending the constitutionality of a state anti-spam law, denying arguments by beauty retailer Ulta that the statute is an undue burden on interstate commerce and runs afoul of federal law.
-
February 04, 2026
Class Attys In Del. Northwest Biotherapeutics Praise Deal
Delaware Chancery Court has lined up a March 16 settlement hearing for a four-year stockholder lawsuit alleging insiders of Northwest Biotherapeutics Inc. received $40 million in stock awards, with proposals including a call for the company to forfeit nearly 22.9 million stock options and it receiving $2.25 million.
-
February 04, 2026
'Extraordinary Circumstances': Elon Musk Faces USAID Depo
A Maryland federal judge on Wednesday said billionaire Elon Musk must testify in litigation filed by U.S. Agency for International Development employees claiming he illegally dismantled the foreign aid agency while head of the advisory organization known as the Department of Government Efficiency, saying "extraordinary circumstances justify the deposition."
-
February 04, 2026
Oracle Oversold AI Infrastructure Spending, Investor Says
An Oracle Corp. shareholder has accused the company in Delaware federal court of overly promising that its increased spending on artificial intelligence infrastructure would accelerate revenue growth despite concerns about its increasing contractual reliance on OpenAI, saying OpenAI itself is beholden to "AI tailwinds continuing and its models being a market leader."
-
February 04, 2026
SEC Cases May Rise After 'Unprecedented' 2025, Attys Say
Following an "unprecedented" year in which the U.S. Securities and Exchange Commission dismissed the bulk of its crypto docket and filed few new lawsuits, former SEC staff members said Wednesday that there are signs that enforcement actions could begin to ramp up this year.
-
February 04, 2026
Under Armour Wants 4th Circ. To Review $100M Coverage Cap
Under Armour asked the Fourth Circuit to review a recent ruling that capped its coverage for a securities class action, government investigations and derivative matters at $100 million, saying the panel overlooked the significance of an endorsement that essentially settled a dispute over when certain claims were made.
-
February 04, 2026
Loeb & Loeb To Guide SPAC's Merger With Packaging Co.
Loeb & Loeb LLP is advising a special purpose acquisition company on its proposed combination with Taiwan-based packaging solutions company Deluxe Technology Group, according to an announcement on Wednesday.
-
February 04, 2026
Chancery Asked For 120-Day Stay Of Virgin Galactic Suit
The Delaware Chancery Court has been asked to temporarily pause a stockholder derivative suit accusing Virgin Galactic founder Richard Branson and other leaders of the spaceflight company of concealing safety risks while selling stock, as related litigation over similar allegations moves toward possible settlement in federal court.
-
February 04, 2026
Drugmakers Say Hagens Berman Responsible For Costs
Drugmakers including GSK and Sanofi have told a Pennsylvania federal court that plaintiffs firm Hagens Berman Sobol Shapiro LLP should bear the costs for the special master tasked with sorting out long-running disputes in a since-dropped product liability suit.
-
February 04, 2026
Wachtel Missry Settles Liability In $26M Atty Malpractice Case
A dispute over who is liable for a former Wachtel Missry LLP partner's alleged exploitation of an elderly client has been settled on the eve of trial, while the Brooklyn federal judge declined to consider recusing himself despite "inadvertently" meeting with the firm's founding partner before the matter was fully put to rest.
-
February 04, 2026
Cooley, Ropes & Gray Transactional Attys Move To Latham
Latham & Watkins LLP announced Tuesday that it has hired two partners to help the firm meet evolving capital and growth demands — a Los Angeles-based emerging companies attorney from Cooley LLP and a New York-based capital markets attorney from Ropes & Gray LLP.
-
February 04, 2026
Stockholders Ask Del. Justices To Revive Bylaw Suits
Stockholders challenging advance notice bylaws at AES Corp. and Owens Corning urged the Delaware Supreme Court on Wednesday to revive their dismissed suits, saying boards should face fiduciary duty scrutiny the moment they adopt allegedly entrenching bylaws, not only after a proxy contest is triggered.
-
February 04, 2026
Ex-Pentagon GC Joins Bradley Arant's National Security Team
Bradley Arant Boult Cummings LLP has hired the former legal adviser to the National Security Council, who is joining the team in Nashville, Tennessee, and Washington, D.C., to work with the firm's Government Enforcement & Investigations and Defense & National Security teams, the firm announced Tuesday.
-
February 04, 2026
Express Scripts Makes 'Fundamental Changes' In FTC Deal
Express Scripts on Wednesday agreed to what the Federal Trade Commission called a "landmark settlement" promising major changes to its drug formulary practices, allowing the company to duck out of a case accusing all three of the country's largest pharmacy benefit managers of inflating insulin prices through rebate schemes.
-
February 03, 2026
XAI Fights Uphill To Keep Alive OpenAI IP Theft Suit
Elon Musk's xAI urged a California federal judge Tuesday to change her tentative decision to toss its suit accusing OpenAI of poaching its workers to steal trade secrets, arguing that when considered together, the "whole gestalt" of xAI's allegations against individual employees is enough to state viable claims against OpenAI.
-
February 03, 2026
Calif. Privacy Agency Taps Meta Alum To Head New Audits Unit
The California Privacy Protection Agency on Tuesday announced the creation of a new Audits Division to assess companies' compliance with the state's consumer data privacy framework and named the most recent director of public policy at social media giant Meta Platforms Inc. to lead the unit.
-
February 03, 2026
ImmunityBio Stockholder Targets Soon-Shiong In Chancery
The Delaware Chancery Court on Tuesday heard arguments over whether biotech billionaire Patrick Soon-Shiong and ImmunityBio Inc.'s board breached their fiduciary duties by approving insider financing that allegedly allowed him to secure equity at deeply discounted prices as the company neared regulatory approval for its lead cancer drug.
-
February 03, 2026
Wachtell Lipton, Davis Polk Steer $12B Santander Deal
Wachtell Lipton Rosen & Katz and Davis Polk & Wardwell LLP are guiding Banco Santander SA's $12.3 billion cash-and-stock acquisition of Webster Financial Corp., according to an announcement made Tuesday.
-
February 03, 2026
Uber Should Pay $144M For Sex Assault By Driver, Jury Told
Uber should pay more than $144 million in compensatory and punitive damages for choosing "profit over safety," leading to the rape of a 19-year-old woman by a rideshare driver, her lawyer told an Arizona federal jury at the close of a landmark bellwether trial on Tuesday.
-
February 03, 2026
Medtronic's Bundling Isn't Anticompetitive, Prof Tells Jury
A University of Chicago economics professor testified Tuesday in a California federal trial over antitrust claims against Medtronic, saying its practice of bundling its advanced bipolar devices for sales with other products isn't anticompetitive but is actually a very common American practice used by the likes of McDonald's and Costco.
-
February 03, 2026
SEC Tosses Biden-Era Case Against Wyoming Crypto Co.
The U.S. Securities and Exchange Commission has walked away from an attempt to block the issuance of a pair of digital tokens offered by a Wyoming-based company, saying that changes in federal policy toward the cryptocurrency industry necessitated an end to the administrative proceedings.
-
February 03, 2026
Chancery Slashes Mootness Fee Proposal In Bolt Suit
A Delaware vice chancellor on Tuesday pruned to $4.1 million a $7.5 million attorney fee request for litigation that ended with cancellation of more than $37 million in Bolt Financial Group shares used by a company controller to secure a later-defaulted-upon, company-guaranteed loan.
Expert Analysis
-
10 Commandments For Agentic AI Tools In The Legal Industry
Though agentic artificial intelligence has demonstrated significant promise for optimizing legal work, it presents numerous risks, so specific ethical obligations should be built into the knowledge base of every agentic AI tool used in the legal industry, says Steven Cordero at Akerman LLP.
-
NY Tax Talk: New ALJs, New Rules, Apportionment, Bundling
Attorneys at Eversheds review the top New York tax law developments from last quarter, including appointments to the New York City Tax Appeals Tribunal and the city's proposed rules to clarify income taxation of foreign corporations, and highlight two litigation matters to watch.
-
Series
Preaching Makes Me A Better Lawyer
Becoming a Gospel preacher has enhanced my success as a trial lawyer by teaching me the importance of credibility, relatability, persuasiveness and thorough preparation for my congregants, the same skills needed with judges and juries in the courtroom, says Reginald Harris at Stinson.
-
Why Digital Asset Treasuries Are Drawing Regulator Concerns
Financial regulators’ recent focus on potential insider trading and investor risk at hundreds of publicly traded digital asset treasuries may have been summoned by how quickly this rapidly expanding market responds to asset allocation decisions, as well as variations in risk disclosure practices across the sector, say attorneys at The Brattle Group.
-
FTC Focus: Amazon's $2.5B Pact Broadens Regulatory Span
Amazon's $2.5 billion deal with the Federal Trade Commission offers takeaways for counsel managing risk across both consumer protection and competition portfolios, including that design strategies once evaluated solely for conversion may now be scrutinized for their competitive effects, say attorneys at Proskauer.
-
SEC Penalties Trended Down In FY 2025, Offering 2026 Clues
The U.S. Securities and Exchange Commission's settled corporate penalties in fiscal year 2025 show a clear dividing line, as the largest penalties all came before Inauguration Day, a trend that may continue as the types of cases that lead to the biggest penalties seem to be no longer favored by the commissioners, say attorneys at Dentons.
-
Series
Law School's Missed Lessons: Practicing Client-Led Litigation
New litigators can better help their corporate clients achieve their overall objectives when they move beyond simply fighting for legal victory to a client-led approach that resolves the legal dispute while balancing the company's competing out-of-court priorities, says Chelsea Ireland at Cohen Ziffer.
-
A Close Look At The Evolving Interval Fund Space
Interval funds — closed-end registered investment companies that make periodic repurchase offers — have recently moved to the center of the conversation about retail access to private markets, spurred along by President Donald Trump's August executive order incorporating alternative assets into 401(k) plans and target date strategies, say attorneys at Simpson Thacher.
-
Meta Monopoly Ruling Highlights Limits Of Market Definition
A D.C. federal court's recent ruling that Meta is not monopolizing social media raises questions, such as why market definition matters and whether we have the correct model of competition, which can aid in making a stronger case against tech companies, says Shubha Ghosh at the Syracuse University College of Law.
-
Perspectives
Nursing Home Abuse Cases Face 3 Barriers That Need Reform
Recent headlines reveal persistent gaps in oversight and protection for vulnerable residents in long-term care, but prosecution of these cases is often stymied by numerous challenges that will require a comprehensive overhaul of regulatory, legal and financial structures to address, says Veronica Finkelstein at Wilmington University.
-
9th Circ. Robinhood Ruling May Alter Intraquarter Disclosures
By aligning with the Second Circuit and rejecting the First Circuit's extreme-departure standard, the Ninth Circuit recently signaled in its decision to revive a putative securities class action against Robinhood a renewed emphasis on transparency when known trends that can be considered material arise between quarterly reports, say attorneys at MoFo.
-
Series
The Law Firm Merger Diaries: How To Build On Cultural Fit
Law firm mergers should start with people, then move to strategy: A two-level screening that puts finding a cultural fit at the pinnacle of the process can unearth shared values that are instrumental to deciding to move forward with a combination, says Matthew Madsen at Harrison.
-
OFSI Proposals Signal Greater Focus On Enforcement Activity
The Office of Financial Sanctions Implementation’s proposed financial sanctions reforms, with risks of higher penalties and more stringent disclosure requirements for U.K. banks and companies, reflect the agency’s evolution into a more sophisticated and robust enforcement regulator, says Irene Polieri at Gibson Dunn.
-
Considerations When Invoking The Common-Interest Privilege
To successfully leverage the common-interest doctrine in a multiparty transaction or complex litigation, practitioners should be able to demonstrate that the parties intended for it to apply, that an underlying privilege like attorney-client has attached, and guard against disclosures that could waive privilege and defeat its purpose, say attorneys at DLA Piper.
-
How In-House Counsel Can Prep Corp. Reps For Depositions
With anticorporate sentiment on the rise and jury verdicts against businesses growing larger, it is crucial that witnesses designated to be deposed on behalf of a company be well-prepared — and there are several key points in-house counsel should keep in mind to facilitate this process, says Joseph Altieri at Hollingsworth.